Australia fumes over Trump's tariff call
Donald Trump has claimed the tariff rate on steel will double to 50 per cent, drawing the ire of the Australian government.
The US President blurted out the latest development in his trade war at a steel mill rally in Pennsylvania, on Saturday morning Australian time.
Australian Trade Minister Don Farrell said the latest tariff hike was unjustified.
'Australia's position has been consistent and clear. These tariffs are unjustified and not the act of a friend,' he said in a statement.
'They are an act of economic self harm that will only hurt consumers and businesses who rely on free and fair trade.
'We will continue to engage and advocate strongly for the removal of the tariffs.' Australian Trade Minister Don Farrell says the US tariffs are not act of a friend. NewsWire / Martin Ollman Credit: News Corp Australia
US government data shows the price of steel products into the US have increased by 16 per cent since Trump's second term began.
Australian car parts, steel and aluminium are currently being slapped with a 25 per cent levy, as per Trump's sweeping protectionist policies.
The Pennsylvania rally on Friday was near a factory owned by US Steel, and the President said Japanese steel giant Nippon had invested in the American firm.
'We're here today to celebrate a blockbuster agreement that will ensure this storeyed American company stays an American company,' the President said.
'You're going to stay an American company, you know that, right?'
'If you don't have steel, you don't have a country. You don't have a country, you can't make a military. What are we going to do? Say, 'Let's go to China to get our steel from the army tanks',' Trump said.
The Trump administration initially promised to block Nippon's bid to buy US Steel. Details of the 'blockbuster agreement' have not been released. Nippon confirmed in a statement a proposed 'partnership' had been agreed to.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
12 minutes ago
- News.com.au
ASX health May winners: Sector rises 1.59pc but market volatility remains
The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump's trade and health policies continue to impact sector Lumos up 7.4% in May after several positive announcements including largest single purchase order for point-of-care respiratory test The S&P/ASX 200 Health Care Index rose 1.59% in May, easing from a 2.16% gain in April but still finishing in the green. However, the sector is still not faring well and is the worst-performing year-to-date, down 5.65%. The sector rose in line with broader markets in May with the S&P/ASX 200 gaining 4.20% as fears around escalating US tariffs and a potential US-China trade war eased, bringing relief to global markets. Morgans healthcare analyst Iain Wilkie told Stockhead that 2025 had been very volatile for the sector. "Each month seems to be either up or down and the sector hasn't gained any real momentum at this stage," he said. Wilkie said US President Donald Trump and his trade and health policies were still impacting the sector. "It's just uncertainty which is driving everything at the moment," he said. In May Trump signed an executive order lowering prices of US prescription medicines to bring them in line with other countries, a policy referred to as the 'most favored nation' (MFN). The MFN policy aims to link US drug prices to much lower prices overseas – what Trump referred to as 'equalizing' prices. Trump said the order aimed to cut US pharmaceutical prices from between 59% to 90% and sets price targets for drugmakers to meet within 30 days and warns that further action will be taken if they fail to make 'significant progress' toward those goals. In a release The White House said the US had less than 5% of the world's population and yet funds around three quarters of global pharmaceutical profits. "There's no clear path on what happens next and consequences pharmaceutical companies may face," Wilkie said. "But its just created further uncertainty in the healthcare and pharmaceutical sectors in an already uncertain time." How ASX biotechs performed in May CODE COMPANY PRICE 1 MONTH RETURN % MARKET CAP DVL Dorsavi Ltd $ 0.02 36.4% 10.97 IVX Invion Ltd $ 0.11 28.0% 8.47 CC5 Clever Culture $ 0.02 26.7% 33.55 VFX Visionflex Group Ltd $ 0.003 25.0% 8.42 NYR Nyrada Inc $ 0.18 24.1% 37.97 IIQ Inoviq Ltd $ 0.55 23.9% 63.07 OSX Osteopore Limited $ 0.02 21.4% 2.95 PEB Pacific Edge $ 0.09 18.7% 60.89 ICR Intelicare Holdings $ 0.01 14.3% 3.89 MVP Medical Developments $ 0.67 11.7% 75.48 PCK Painchek Ltd $ 0.06 11.5% 106.83 IRX Inhalerx Limited $ 0.03 11.1% 6.40 ALA Arovella Therapeutic $ 0.08 11.0% 88.79 IPD Impedimed Limited $ 0.03 10.0% 66.91 LGP Little Green Pharma $ 0.11 10.0% 34.96 ATH Alterity Therapeutics $ 0.01 10.0% 100.40 DOC Doctor Care Anywhere $ 0.11 10.0% 38.50 AGH Althea Group $ 0.03 8.7% 20.56 ALC Alcidion Group Ltd $ 0.09 8.6% 114.15 HMD Heramed Limited $ 0.01 8.3% 11.38 MDR Medadvisor Limited $ 0.09 8.1% 57.48 RAD Radiopharm $ 0.03 8.0% 65.35 LDX Lumos Diagnostics $ 0.03 7.4% 21.71 AVR Anteris Technologies $ 6.29 6.6% 99.41 AFP AFT Pharmaceuticals $ 2.60 6.1% 272.65 ARX Aroa Biosurgery $ 0.49 5.4% 165.55 UCM Uscom Limited $ 0.02 5.3% 4.76 RHC Ramsay Health Care $ 37.90 5.1% 7,049.83 CVB Curvebeam Ai Limited $ 0.09 4.9% 26.97 REG Regis Healthcare Ltd $ 8.13 4.9% 1,242.92 TRI Trivarx Ltd $ 0.01 4.8% 6.79 ACR Acrux Limited $ 0.02 4.3% 9.79 VLS Vita Life Sciences $ 1.89 4.1% 104.29 PGC Paragon Care Limited $ 0.40 3.9% 662.12 NSB Neuroscientific $ 0.06 3.8% 7.95 CMP Compumedics Limited $ 0.28 3.7% 53.82 SPL Starpharma Holdings $ 0.09 3.4% 38.48 NOX Noxopharm Limited $ 0.07 2.9% 21.04 GLH Global Health Ltd $ 0.08 2.6% 4.63 CMB Cambium Bio Limited $ 0.21 2.5% 3.75 PIQ Proteomics Int Lab $ 0.42 2.4% 59.56 SDI SDI Limited $ 0.85 2.4% 99.25 CSX Cleanspace Holdings $ 0.45 2.3% 34.81 ATX Amplia Therapeutics $ 0.05 2.0% 19.40 MVF Monash IVF Group Ltd $ 0.78 2.0% 301.97 IDX Integral Diagnostics $ 2.43 1.9% 870.95 EZZ EZZ Life Science $ 1.54 1.7% 72.65 IMC Immuron Limited $ 0.07 1.5% 15.67 FRE Firebrickpharma $ 0.07 1.5% 15.05 SHL Sonic Healthcare $ 26.62 1.4% 12,821.98 FPH Fisher & Paykel Healthcare $ 34.59 1.4% 6,585.46 IMR Imricor Med Systems $ 1.67 1.2% 541.55 OCC Orthocell Limited $ 1.27 1.2% 307.31 PME Pro Medicus Limited $ 280.98 0.9% 15,316.67 PAR Paradigm Biopharmaceuticals $ 0.31 0.8% 120.72 CTE Cryosite Limited $ 0.75 0.7% 36.61 CHM Chimeric Therapeutic $ 0.00 0.0% 8.06 IXC Invex Therapeutics $ 0.09 0.0% 6.99 COV Cleo Diagnostics $ 0.35 0.0% 27.74 IDT IDT Australia Ltd $ 0.10 0.0% 45.12 EYE Nova EYE Medical Ltd $ 0.13 0.0% 35.52 OCA Oceania Healthc Ltd $ 0.59 0.0% 427.30 EPN Epsilon Healthcare $ 0.02 0.0% 8.29 TD1 Tali Digital Limited $ 0.00 0.0% 3.30 OIL Optiscan Imaging $ 0.13 0.0% 112.77 PER Percheron $ 0.01 0.0% 10.87 OSL Oncosil Medical $ 1.20 0.0% 13.82 BIT Biotron Limited $ 0.00 0.0% 3.32 EOF Ecofibre Limited $ 0.02 0.0% 7.58 TRP Tissue Repair $ 0.19 0.0% 11.19 IBX Imagion Biosys Ltd $ 0.01 0.0% 2.42 SOM SomnoMed Limited $ 0.59 0.0% 129.66 ANR Anatara Ls Ltd $ 0.01 0.0% 1.07 HIQ Hitiq Limited $ 0.02 0.0% 7.57 ADR Adherium Ltd $ 0.01 0.0% 5.31 PSQ Pacific Smiles Grp $ 1.81 -0.3% 291.73 COH Cochlear Limited $ 271.60 -0.4% 17,779.29 CSL CSL Limited $ 247.16 -0.7% 119,986.49 TLX Telix Pharmaceutical $ 25.98 -0.8% 7,546.94 HLS Healius $ 0.88 -0.8% 635.37 ANN Ansell Limited $ 31.19 -0.9% 4,566.62 SNZ Summerset Grp Hldgs $ 10.21 -0.9% 2,461.11 MYX Mayne Pharma Ltd $ 4.80 -1.0% 376.51 RGT Argent Biopharma Ltd $ 0.09 -1.1% 6.86 PNV Polynovo Limited $ 1.27 -1.2% 870.46 PYC PYC Therapeutics $ 1.20 -1.2% 699.91 BDX Bcal Diagnostics $ 0.08 -1.3% 27.45 NEU Neuren Pharmaceuticals $ 13.85 -1.4% 1,765.00 RMD ResMed Inc. $ 37.58 -1.5% 22,360.10 IME Imexhs Limited $ 0.33 -1.5% 17.70 LTP LTR Pharma $ 0.32 -1.5% 34.71 AHC Austco Healthcare $ 0.31 -1.6% 112.86 RHY Rhythm Biosciences $ 0.06 -1.6% 17.87 ONE Oneview Healthcare $ 0.27 -1.9% 202.31 VHL Vitasora Health Ltd $ 0.04 -2.4% 66.24 MSB Mesoblast Limited $ 1.60 -2.4% 1,560.40 CYC Cyclopharm Limited $ 1.18 -2.5% 131.70 AHX Apiam Animal Health $ 0.39 -2.5% 71.74 EBO Ebos Group Ltd $ 34.69 -2.5% 1,365.85 IMM Immutep Ltd $ 0.28 -2.6% 407.57 VIT Vitura Health Ltd $ 0.07 -2.9% 45.03 CUV Clinuvel Pharmaceuticals $ 10.24 -3.0% 457.13 AVH Avita Medical $ 1.89 -3.1% 123.08 NAN Nanosonics Limited $ 4.39 -3.1% 1,282.02 NUZ Neurizon Therapeutic $ 0.15 -3.3% 68.92 MAP Microba Life Sciences $ 0.15 -3.3% 64.94 BMT Beamtree Holdings $ 0.28 -3.4% 81.15 SIG Sigma Health Ltd $ 3.06 -3.5% 17,428.00 MX1 Micro-X Limited $ 0.06 -3.5% 36.70 CGS Cogstate Ltd $ 1.30 -3.5% 219.41 NC6 Nanollose Limited $ 0.05 -3.8% 15.24 RCE Recce Pharmaceutical $ 0.34 -4.2% 90.39 AYA Artrya $ 0.73 -4.6% 82.43 ACW Actinogen Medical $ 0.02 -4.8% 63.54 DXB Dimerix Ltd $ 0.58 -4.9% 326.72 ACL Au Clinical Labs $ 2.78 -5.1% 395.94 EBR EBR Systems $ 1.09 -5.2% 465.57 NXS Next Science Limited $ 0.07 -5.6% 19.57 EMV Emvision Medical $ 1.68 -5.6% 140.67 AT1 Atomo Diagnostics $ 0.02 -5.9% 10.98 PTX Prescient Ltd $ 0.05 -6.0% 37.85 AGN Argenica $ 0.77 -6.1% 98.63 M7T Mach7 Tech Ltd $ 0.35 -6.7% 84.43 BOT Botanix Pharma Ltd $ 0.35 -6.8% 620.71 ZLD Zelira Therapeutics $ 0.46 -7.1% 5.71 SNT Syntara Limited $ 0.07 -7.1% 105.57 CAN Cann Group Ltd $ 0.01 -7.1% 8.09 TYP Tryptamine Ltd $ 0.03 -8.6% 44.45 NTI Neurotech International $ 0.02 -8.7% 22.04 SHG Singular Health $ 0.30 -9.1% 83.31 ECS ECS Botanics Holding $ 0.01 -9.1% 14.26 GSS Genetic Signatures $ 0.49 -9.3% 110.16 CBL Control Bionics $ 0.03 -9.7% 8.84 ILA Island Pharma $ 0.21 -10.6% 49.05 UBI Universal Biosensors $ 0.04 -10.6% 12.52 EMD Emyria Limited $ 0.03 -10.7% 13.75 TRU Truscreen $ 0.02 -11.1% 13.32 RHT Resonance Health $ 0.04 -11.6% 20.22 RAC Race Oncology Ltd $ 1.21 -12.0% 210.22 4DX 4DMedical Limited $ 0.31 -12.9% 146.64 CYP Cynata Therapeutics $ 0.17 -13.2% 37.28 CU6 Clarity Pharma $ 1.91 -13.8% 535.84 CDX Cardiex Limited $ 0.04 -16.1% 17.87 1AI Algorae Pharma $ 0.01 -16.7% 8.44 TRJ Trajan Group Holding $ 0.77 -16.8% 116.57 IMU Imugene Limited $ 0.01 -17.6% 112.01 MEM Memphasys Ltd $ 0.00 -18.2% 7.93 AVE Avecho Biotech Ltd $ 0.00 -20.0% 12.69 BP8 Bph Global Ltd $ 0.00 -20.0% 2.10 VBS Vectus Biosystems $ 0.05 -21.7% 2.50 CTQ Careteq Limited $ 0.01 -23.1% 2.37 1AD Adalta Limited $ 0.00 -33.3% 1.93 Inoviq (ASX:IIQ) rose ~24% in May and got hit with a speeding ticket by the ASX. The oncology play had no particular news out in May and attributed the increase to publication online of an abstract accepted by the American Society of Clinical Oncology (ASCO) for a poster presentation about results of its EXO-OC test for ovarian cancer. Inoviq said the result had already been released in December and referred to in subsequent business updates. "Some shareholders may have missed or misunderstood the significance of our 3 December 2024 ASX release and subsequent related updates noted above and may believe the Abstract contains new or better information, which is materially price sensitive, that is not the case in the company's view. The company said new information to be delivered in the poster presentation at the ASCO annual meeting on June 1 was "considered price sensitive". On June 2 Inoviq announced that new data presented at the ASCO meeting showed its EXO-OC test achieved 77% sensitivity at 99.6% specificity for detecting ovarian cancer at all stages. Clever Culture Systems (ASX:CC5) continued to build momentum in May and was up 26.7% for the month after announcing a positive quarterly update in April, including its second quarter of positive cashflow. Clever Culture is targeting profitability in FY25 and building a substantial sales pipeline to underpin growth in FY26 for its APAS Independence instruments, which remain the only US FDA-cleared AI technology for automated culture plate reading. Lumos Diagnostics (ASX:LDX) rose 7.4% in May after several positive announcements including the largest single purchase order to date for its FebriDx test, a rapid point-of-care (POC) diagnostic designed to differentiate between bacterial and non-bacterial acute respiratory infections. Developer and distributor of cost-saving solutions for hospitals, surgery centres, clinics and healthcare facilities across the US iMedical purchased US$126,000 worth of FebriDx tests. In May Lumos also expanded Medicare reimbursement coverage in the US for FebriDx. By the end of May Lumos had secured reimbursement from six out of seven US Medicare Administrative Contractors (MACs) representing over 85% of US Medicare payment coverage. And Australia's biggest private hospital operator Ramsay Health Care (ASX:RHC) rose 5.1% in May after providing a positive update on its 52.8% stake in European hospitals business Santé, with unaudited group revenue for the nine months period ending March 31, up by 5.1%.
Mercury
20 minutes ago
- Mercury
ASX tech May winners: Silicon surge sends Aussie tech sector skyward by 22pc
ASX tech stocks roared back to life in May, riding a wave of global AI hype, easing trade tensions, and strong earnings. Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. ASX tech rockets 22pc in May Earnings from tech's 'Magnificent 7' helped matters Elsight, Eroad, Etherstack and Yojee were notable gainers The ASX tech sector didn't just rally in May, it rocketed. Up more than 22%, it was one of the biggest monthly leaps in recent memory, outpacing every other sector on the index and riding a wave of global tailwinds that swept through Wall Street and into Martin Place. May performance by sector So what lit the rocket under Aussie tech? Well, a combo of softening US-China trade tensions, a rate cut by the RBA, and red-hot earnings from the global tech elite – all wrapped in a volatile month where every diplomatic handshake or tariff tweet sent markets bouncing. Wall Street turns silicon slick Over in the US, it was an AI-fuelled tech fest. The Nasdaq jumped 9.5% in May, its best showing since November last year. The S&P 500 had a solid 6.15% lift, and the Dow chipped in with a 4% gain. The key driver was de-escalation. Starting May 14, Washington slashed tariffs on Chinese goods from 145% to 30%. Beijing responded by trimming its own to 10%. Also, earnings from the 'Magnificent Seven' – Microsoft, Nvidia, Apple, Alphabet, Amazon, Meta, and Tesla – blew past expectations. According to FactSet, their collective Q1 earnings grew 27.7%, smashing estimates and fuelling confidence in AI, cloud, and consumer spending. But the mood wasn't all champagne and confetti. Trump reignited tariff threats by month's end, accusing China of dragging its feet on export compliance, especially around rare earths. The backpedalling stirred new worries, but not enough to undo the market's momentum. Confidence is back, at least for now. And when global investors are feeling bold, ASX tech stocks often get caught in the updraft. ASX tech winners in May Code Name Price Month % Change Market Cap 4DS 4Ds Memory Limited 0.059 97% $118,137,090 ELS Elsight Ltd 0.770 71% $139,940,732 ERD Eroad Limited 1.390 65% $260,500,778 ESK Etherstack PLC 0.440 54% $58,155,681 YOJ Yojee Limited 0.270 54% $86,413,050 360 Life360 Inc. 33.330 52% $5,806,753,611 EOS Electro Optic Sys. 1.845 51% $355,996,623 CAT Catapult Grp Int Ltd 5.850 43% $1,427,690,903 XPN Xpon Technologies 0.010 43% $4,142,532 SPX Spenda Limited 0.007 40% $32,306,508 VNL Vinyl Group Ltd 0.130 38% $163,717,420 TNE Technology One 41.060 37% $13,346,815,417 RCL Readcloud 0.135 35% $20,738,668 DCC Digitalx Limited 0.070 35% $84,253,672 W2V Way2Vatltd 0.008 33% $11,302,865 VIG Victor Group Hldgs 0.082 32% $53,482,587 GTI Gratifii 0.099 32% $33,540,151 JCS Jcurve Solutions 0.033 32% $10,901,333 AI1 Adisyn Ltd 0.066 32% $47,726,289 AD8 Audinate Group Ltd 7.950 29% $658,524,993 IKE Ikegps Group Ltd 0.920 29% $148,177,677 CGO CPT Global Limited 0.063 26% $2,639,534 SMP Smartpay Holdings 0.945 25% $227,426,856 NVU Nanoveu Limited 0.048 23% $38,578,586 OCL Objective Corp 19.230 23% $1,838,200,431 VR1 Vection Technologies 0.022 22% $38,878,882 ASV Assetvisonco 0.039 22% $28,835,101 BCC Beam Communications 0.120 21% $10,370,631 WTC Wisetech Global Ltd 107.150 21% $36,396,942,187 FL1 First Lithium Ltd 0.078 20% $6,212,981 OAK Oakridge 0.072 20% $1,943,849 MP1 Megaport Limited 13.520 18% $2,242,455,288 SP3 Specturltd 0.013 18% $4,005,952 EOL Energy One Limited 14.750 18% $462,123,149 XF1 Xref Limited 0.135 17% $29,712,118 EVS Envirosuite Ltd 0.084 17% $121,691,110 SLX Silex Systems 3.600 17% $802,416,290 BVS Bravura Solution Ltd 2.550 16% $1,143,302,705 EML EML Payments Ltd 1.130 16% $431,773,255 CDA Codan Limited 18.000 14% $3,237,408,113 DTI DTI Group Ltd 0.007 14% $3,139,860 RDY Readytech Holdings 2.380 13% $290,693,379 OLL Openlearning 0.017 13% $8,205,469 AXE Archer Materials 0.300 13% $76,454,104 ID8 Identitii Limited 0.009 13% $7,002,122 XRO Xero Ltd 184.290 12% $28,534,797,978 RUL Rpmglobal Hldgs Ltd 3.070 12% $686,816,448 HCL Highcom Ltd 0.200 11% $20,536,534 BEO Beonic Ltd 0.200 11% $14,172,202 NXT Nextdc Limited 13.110 11% $8,415,067,423 SNS Sensen Networks Ltd 0.031 11% $24,584,162 SMN Structural Monitor. 0.430 10% $66,394,171 RKT Rocketdna Ltd. 0.011 10% $10,070,756 ZMM Zimi Ltd 0.011 10% $4,702,982 TYR Tyro Payments 0.885 10% $467,587,600 AR9 Archtis Limited 0.070 9% $20,157,701 DUG DUG Tech 1.120 9% $150,816,513 IRE IRESS Limited 8.660 9% $1,608,257,371 ROC Rocketboots 0.088 9% $12,815,075 KYP Kinatico Ltd 0.195 8% $84,257,937 SEN Senetas Corporation 0.020 8% $33,120,382 5GN 5G Networks Limited 0.140 8% $41,697,847 COS Cosol Limited 0.785 8% $142,861,205 ODA Orcoda Limited 0.079 7% $14,813,623 IRI Integrated Research 0.440 6% $78,035,192 FCL Fineos Corp Hold PLC 2.320 6% $785,319,223 DXN DXN Limited 0.036 6% $10,753,331 VGL Vista Group Int Ltd 3.470 6% $828,755,302 GTK Gentrack Group Ltd 11.390 5% $1,170,937,010 QOR Qoria Limited 0.415 5% $542,232,890 FLX Felix Group 0.210 5% $42,944,940 XYZ Block Inc 96.510 5% $5,298,308,114 UBN Ltd 0.840 4% $66,058,362 LVE Love Group Global 0.125 4% $5,066,771 ASB Austal Limited 5.520 4% $2,274,372,238 PHX Pharmx Technologies 0.080 4% $47,880,543 PPK PPK Group Limited 0.315 3% $28,605,937 WBT Weebit Nano Ltd 1.820 3% $419,949,381 OEC Orbital Corp Limited 0.092 2% $14,994,954 RKN Reckon Limited 0.490 2% $55,514,468 DTL Data#3 Limited 7.430 2% $1,158,714,331 NXL Nuix Limited 2.480 2% $813,603,994 DSE Dropsuite Ltd 5.880 1% $418,227,407 PRO Prophecy Internation 0.430 1% $31,712,042 Making news for the right reasons or just hitting milestones, here were some of the month's notable gainers… Elsight (ASX:ELS) Elsight's share price ripped higher in May after it secured a second major contract from a European defence drone maker, worth US$5.35m on top of an earlier US$4.28m deal announced in April. That brings the customer's total commitment to US$9.63m, with all units set for delivery this year. Elsight's Halo tech is being embedded into defence drone programs, and more than US$1m of the April order has already been delivered and booked as revenue. On top of that, Elsight was selected by Northrop Grumman for a prestigious US defence accelerator, just 8 companies chosen from over 225 applicants. That program gives it direct access to Northrop's tech and procurement teams, and a fast-track to potential US DoD contracts. Eroad (ASX:ERD) Transport tech firm Eroad surged after delivering a strong FY25 result and setting upbeat guidance for the year ahead. It flipped to a profit, pulled in NZ$16m in free cash flow (a huge jump from NZ$1.3m last year), and saw revenue climb to NZ$194.4m, up nearly 7%. Annual recurring revenue (ARR) also rose to NZ$175.1m. But it was the outlook that really got investors paying attention. Eroad is guiding to FY26 revenue of at least NZ$205m, and ARR of at least NZ$188m, with free cash flow yield of 8–10%. It's also targeting medium-term ARR growth of 11–13%. Etherstack (ASX:ESK) Radio tech firm Etherstack popped in May after locking in a record US$7m in cash receipts for the first half of FY25, its strongest half-year since listing. Most of that came from project revenue already delivered, and it reckons H1 revenue alone could beat all of last year's full result. It's also flagged more big deals likely coming soon from long-term clients, and its recurring revenue from support and 'comms-as-a-service' is steadily growing. All up, investors saw strong cash, solid outlook, and momentum. Yojee (ASX:YOJ) Logistics tech minnow Yojee surged in May off the back of two big catalysts. First, it presented at the IFCBAA national freight conference, putting its next-gen freight forwarding software in front of key industry players. Second, WiseTech's massive $2.1bn acquisition of E2open lit a fire under the whole sector, showing just how hot logistics tech is right now. Now read: WiseTech's $2bn power play, and one small logistics tech stock stirring interest Yojee's building its own momentum too, with an AI assistant baked into its platform, and a pilot deal with global player Röhlig Logistics kicking off in Singapore. All up, investors saw a small-cap riding a big wave, and jumped on board. ASX tech losers in May Code Name Price Month % Change Market Cap DUB Dubber Corp Ltd 0.016 -61% $41,973,880 1TT Thrive Tribe Tech 0.001 -50% $2,031,723 DTZ Dotz Nano Ltd 0.048 -36% $28,323,086 BLG Bluglass Limited 0.011 -31% $22,198,234 FCT Firstwave Cloud Tech 0.013 -28% $22,275,743 OPL Opyl Limited 0.019 -27% $4,464,398 EIQ Echoiq Ltd 0.245 -26% $158,070,989 SIS Simble Solutions 0.003 -25% $2,628,991 BRN Brainchip Ltd 0.205 -24% $435,534,473 SKO Serko 2.720 -22% $338,912,408 SPA Spacetalk Ltd 0.160 -22% $12,395,156 DWG Dataworks Group 0.130 -21% $13,289,126 HTG Harvest Tech Grp Ltd 0.016 -20% $14,335,148 KNO Knosys Limited 0.035 -19% $7,564,854 NOV Novatti Group Ltd 0.022 -19% $11,950,156 RWL Rubicon Water 0.210 -18% $50,545,971 FBR FBR Ltd 0.005 -17% $28,447,261 NOR Norwood Systems Ltd. 0.020 -17% $10,318,553 JAN Janison Edu Group 0.140 -15% $36,384,355 IFG Infocusgroup Hldltd 0.006 -14% $1,574,561 NVQ Noviqtech Limited 0.027 -13% $6,791,487 HYD Hydrix Limited 0.014 -13% $3,818,764 EPX Ept Global Limited 0.023 -12% $15,150,929 AJX Alexium Int Group 0.008 -11% $12,691,429 8CO 8Common Limited 0.016 -11% $3,585,518 IOD Iodm Limited 0.130 -10% $77,070,523 CYB Aucyber Limited 0.080 -10% $16,751,735 3DP Pointerra Limited 0.055 -8% $44,279,224 ACE Acusensus Limited 0.970 -8% $135,825,086 CF1 Complii Fintech Ltd 0.025 -7% $14,284,841 ICE Icetana Limited 0.014 -7% $6,133,997 MX1 Micro-X Limited 0.056 -7% $37,363,326 WHK Whitehawk Limited 0.014 -7% $10,378,849 XRG Xreality Group Ltd 0.030 -6% $19,906,426 SOR Strategic Elements 0.032 -6% $15,236,274 HSN Hansen Technologies 5.100 -6% $1,047,697,081 AT1 Atomo Diagnostics 0.017 -6% $11,321,179 X2M X2M Connect Limited 0.019 -5% $7,375,455 TZL TZ Limited 0.059 -5% $16,556,232 BDT Birddog 0.047 -4% $7,589,843 CXZ Connexion Mobility 0.026 -4% $21,216,424 CML Connected Minerals 0.130 -4% $5,376,568 IFM Infomedia Ltd 1.210 -2% $471,132,514 AVA AVA Risk Group Ltd 0.103 -2% $30,499,563 DDR Dicker Data Limited 8.230 -2% $1,473,911,938 CCR Credit Clear 0.230 -2% $97,669,188 PPS Praemium Limited 0.730 -2% $348,732,077 DRO Droneshield Limited 1.315 -2% $1,127,576,305 ATA Atturralimited 0.860 -2% $328,224,812 CPU Computershare Ltd 40.220 -1% $23,657,729,209 NVX Novonix Limited 0.420 -1% $283,058,021 This story does not constitute financial product advice. You should consider obtaining independent advice before making any financial decision. Originally published as ASX tech May winners: Silicon surge sends Aussie tech sector skyward by 22pc Stockhead The S&P/ASX 200 Health Care Index rose 1.59% in May, easing from a 2.16% gain in April but still finishing in the green. Stockhead As tensions rise in the Indo-Pacific, Aussie tech players like Vection, DroneShield and Harvest are quietly stepping into the spotlight
West Australian
32 minutes ago
- West Australian
China's restaurants replace American beef with Australian beef amid trade war: reports
Restaurants in China are reportedly switching out American beef for Australian beef due to Donald Trump's tariffs. The US President triggered a trade war with Beijing by slapping meaty tariffs on Chinese goods. An ensuing tit-for-tat escalation peaked with the US imposing 145 per cent levies on Chinese products and China imposing 125 per cent duties on American products. Both sides have since backed down, with Washington agreeing to 30 per cent imposts on goods from China and Beijing agreeing to 10 per cent on US imports. But the tariffs have still hiked American beef supply costs for restaurants in the Chinese capital, prompting them to look to tariff-free Australian beef. Chinese state media reported on Tuesday that an American-themed restaurant in Beijing had made the switch because of 'cost pressures and declining supply stability of US imports'. The Global Times reported it spoke with a staff member at a 'branch of a restaurant famous for its American-style barbecue in Beijing'. The staff member said the restaurant 'stopped serving imported beef from the US starting from about one month ago due to the impact of tariffs', the Chinese government mouthpiece reported. The Global Times did not name the chain, but US business news channel CNBC has also reported that restaurants in Beijing are changing to Australian beef, including one eatery's 'The Great American' burger. A beef supplier told the network that American 'beef is fattier and tastier' but the 'high price is just too much to bear'. Australian beef is exported to China without any duties under the China-Australia Free Trade Agreement. The Albanese government last year also cleared trade barriers for $20bn in Australian goods headed for Chinese ports, including lobsters.
